IGF2BP2 and thyroid cancer: In conclusion, our study elucidates a novel thyroid-specific regulatory axis involving IGF2BP2 and STAT1 that drives dedifferentiation and enhances stemness in diverse subtypes of differentiated thyroid cancers.